Worldwide Cardiac Surgical Devices market is valued at 1790 million US$ in 2018 & will exceed sales of 2340 million US$ by the end of 2025, growing at a CAGR of 3.4% during 2019-2025 | Global Top Players are: Edwards Life Science Corporation, Medtronic Inc., Getinge Group, Atrion Corporation, Abbott Laboratories, Sorin S.P.A., Terumo Medical Corporation, Boston Scientific Corporation, Cook Medical, Angiodynamics, Inc., C. R. Bard, Inc., Trinity Biotech, Abiomed, Inc., Cardinal Health, CyberHeart Incorporated, MedWaves Incorporated, Transmedics, Inc.|

Worldwide Cardiac Surgical Devices market is valued at 1790 million US$ in 2018 & will exceed sales of 2340 million US$ by the end of 2025, growing at a CAGR of 3.4% during 2019-2025 | Global Top Players are: Edwards Life Science Corporation, Medtronic Inc., Getinge Group, Atrion Corporation, Abbott Laboratories, Sorin S.P.A., Terumo Medical Corporation, Boston Scientific Corporation, Cook Medical, Angiodynamics, Inc., C. R. Bard, Inc., Trinity Biotech, Abiomed, Inc., Cardinal Health, CyberHeart Incorporated, MedWaves Incorporated, Transmedics, Inc.|

Press Release

There is a high prevalence of cardiac diseases worldwide, hence an increase in the number of cardiac surgeries. Products such as beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable are used for cardiac surgery.
The key factors that drive the growth of cardiac surgical devices market include rise in incidence & prevalence of cardiovascular diseases. In addition, the rise in healthcare expenditure and healthcare insurance are expected to fuel the market growth during the analysis period. However, shortage of experienced healthcare professionals and lack of awareness among the population restrict the growth.

The global Cardiac Surgical Devices market is valued at 1790 million US$ in 2018 is expected to reach 2340 million US$ by the end of 2025, growing at a CAGR of 3.4% during 2019-2025.
This report focuses on Cardiac Surgical Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Surgical Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The report includes an in-depth analysis of the competitive landscape of this business vertical, constituting manufacturers like:
Edwards Life Science Corporation
Medtronic Inc.
Getinge Group
Atrion Corporation
Abbott Laboratories
Sorin S.P.A.
Terumo Medical Corporation
Boston Scientific Corporation
Cook Medical
Angiodynamics, Inc.
C. R. Bard, Inc.
Trinity Biotech
Abiomed, Inc.
Cardinal Health
CyberHeart Incorporated
MedWaves Incorporated
Transmedics, Inc.

Market Segment by Regions includes:
North America
Europe
China
Japan

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:
Beating Heart Surgery Systems
Cardiopulmonary Bypass Equipment
Cardiac Ablation Devices
Perfusion Disposables

By Industrial Application, the market can be split into:
Congenital Heart Defects
Cardiac Arrhythmia
Coronary Heart Disease
Congestive Heart Failure
Applications

Market Segment by Regions includes:

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America
  • Middle East and Africa.

Browse contents of Global Cardiac Surgical Devices Market Research Report 2019

Contacts

Trusted Business Insights
Joseph Anthony Jones
Senior Media & Marketing Executive
US: +1 646 568 9797
UK: +44 330 808 0580

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,